FDA Enforcement Priorities: Eye Products, Dual Drug/Cosmetic Firms
This article was originally published in The Rose Sheet
Executive Summary
When FDA inspects a facility producing both drugs and cosmetics, the manufacturer should be using one standard and that’s the drug standard, says Karyn Campbell, director of the investigations branch at FDA’s Philadelphia District Office.